7-year-old’s GLP-1 overdose spotlights rising safety concerns with popular meds
With GLP-1 prescriptions surging for diabetes and weight loss, a 7-year-old's self-injection and hospitalization spotlight a nationwide rise in GLP-1–related poison-center calls, driven mainly by accidental dosing; experts warn of dehydration, renal risk, and even pancreatitis, urging careful dosing, secure storage, and reputable sourcing to prevent misuse and counterfeit drugs.